Epidermal growth factor receptor

Basic Information


Uniprot ID: P00533
Secondary ID: O00688
Symbol: EGFR
Other Name: ERBB,Proto-oncogene c-ErbB-1,Receptor tyrosine-protein kinase erbB-1
Class: Single Protein
Type: pro-fibrotic
Molecular Function: Developmental protein,Host cell receptor for virus entry,Kinase,Receptor,Transferase,Tyrosine-protein kinase


Target Classification


Category I Category II Category III
Extracellular Growth factor and receptor EGFR family

Related Compound


Target ID Name Interaction
D0071 AG1478 antagonist
D0072 EGFR-IN-542 inhibitor
D0134 Erlotinib antagonist
D0220 Compound 451 inhibitor
D0324 Gefitinib antagonist

Fibrosis Related Property


Reference Record 1

PubMed ID 28374780 Compound ID D0071
CAS 153436-53-4 Name AG1478
Model vitro,mice Fibrosis Disease Vascular fibrosis
Process I
Process II
Process III prevenet collagen deposition
Mechanism

Reference Record 2

PubMed ID 28374780 Compound ID D0072
CAS 1639040-81-5 Name EGFR-IN-542
Model vitro,mice Fibrosis Disease Vascular fibrosis
Process I
Process II
Process III prevenet collagen deposition
Mechanism

Reference Record 3

PubMed ID 27317889 Compound ID D0134
CAS 183321-74-6 Name Erlotinib
Model vitro,rat Fibrosis Disease Renal fibrosis
Process I
Process II cell activation
Process III prevenet collagen deposition
Mechanism Targeting Aldosterone-ROS-EGFR-ERK1/2 signaling

Reference Record 4

PubMed ID 27317889 Compound ID D0071
CAS 153436-53-4 Name AG1478
Model vitro,rat Fibrosis Disease Renal fibrosis
Process I
Process II cell activation
Process III prevenet collagen deposition
Mechanism Targeting Aldosterone-ROS-EGFR-ERK1/2 signaling

Reference Record 5

PubMed ID 27087279 Compound ID D0071
CAS 153436-53-4 Name AG1478
Model vitro,mice Fibrosis Disease Cardiac fibrosis
Process I attenue inflammation
Process II
Process III prevenet collagen deposition
Mechanism Targeting TLR4 and c-Src

Reference Record 6

PubMed ID 27087279 Compound ID D0072
CAS 1639040-81-5 Name EGFR-IN-542
Model vitro,mice Fibrosis Disease Cardiac fibrosis
Process I attenue inflammation
Process II
Process III prevenet collagen deposition
Mechanism Targeting TLR4 and c-Src

Reference Record 7

PubMed ID 25758431 Compound ID D0220
CAS 220576-72-7 Name Compound 451
Model vitro,mice Fibrosis Disease Cardiac fibrosis
Process I
Process II cells apoptosis
Process III prevenet collagen deposition
Mechanism

Reference Record 8

PubMed ID 25758431 Compound ID D0071
CAS 153436-53-4 Name AG1478
Model vitro,mice Fibrosis Disease Cardiac fibrosis
Process I
Process II cells apoptosis
Process III prevenet collagen deposition
Mechanism

Reference Record 9

PubMed ID 24303948 Compound ID D0071
CAS 153436-53-4 Name AG1478
Model vitro,rat Fibrosis Disease Liver fibrosis
Process I
Process II HSCs proliferation,cells apoptosis
Process III
Mechanism

Reference Record 10

PubMed ID 23086930 Compound ID D0071
CAS 153436-53-4 Name AG1478
Model vitro,mice Fibrosis Disease Idiopathic pulmonary fibrosis
Process I
Process II fibroblasts proliferation,myofibroblasts differentiation
Process III prevenet collagen deposition
Mechanism Targeting EGFR signaling

Reference Record 11

PubMed ID 23086930 Compound ID D0324
CAS 184475-35-2 Name Gefitinib
Model vitro,mice Fibrosis Disease Idiopathic pulmonary fibrosis
Process I
Process II fibroblasts proliferation,myofibroblasts differentiation
Process III prevenet collagen deposition
Mechanism Targeting EGFR signaling

Reference Record 12

PubMed ID 22095949 Compound ID D0134
CAS 183321-74-6 Name Erlotinib
Model vitro,mice Fibrosis Disease Renal fibrosis
Process I
Process II
Process III prevenet collagen deposition
Mechanism

Reference Record 13

PubMed ID 20097367 Compound ID D0071
CAS 153436-53-4 Name AG1478
Model rat Fibrosis Disease Biliary fibrosis
Process I
Process II
Process III prevenet collagen deposition
Mechanism